Is Ascendis Pharma A/S (ASND) a Buy, Sell, or Hold?
Ascendis Pharma A/S
NASDAQ:ASND
$265.57 USD
$0.35 (0.13%)
- Volume
- 516.49K
- Average Volume
- 775.62K
- Market Capitalization
- $16.49B
- P/E Ratio
- 28.40
- Dividend Yield
- 0.00%
- Price Target
- $276.50
- Year High
- $282.15
- Year Low
- $160.86
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-4.0% DOWNSIDE
$276.50 Price Target
UPSIDE/DOWNSIDE HIGH
-23.0% DOWNSIDE
$345.00 Price Target High
UPSIDE/DOWNSIDE LOW
4.1% UPSIDE
$255.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Alex Thompson | $332 | $241.38 | 2026-03-04 03:22 PM | 37.5% |
| Wolfe Research | Kalpit Patel | $260 | $231.4606 | 2026-03-02 10:59 AM | 12.3% |
| Cantor Fitzgerald | Li Watsek | $300 | $231.4284 | 2026-03-02 10:38 AM | 29.6% |
| Evercore ISI | Josh Schimmer | $324 | $234.07 | 2026-03-02 10:03 AM | 38.4% |
| Goldman Sachs | Paul Choi | $255 | $233.5 | 2026-03-02 04:55 AM | 9.2% |